135
Views
9
CrossRef citations to date
0
Altmetric
Gastrointestinal Cancer

Aneuploidy characterizes adjacent non-malignant mucosa of ulcerative colitis-associated but not sporadic colorectal carcinomas: a matched-pair analysis

, , , , , & show all
Pages 679-687 | Received 06 Jan 2013, Accepted 01 Mar 2013, Published online: 02 Apr 2013

References

  • Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001;91:854–62.
  • Jawad N, Direkze N, Leedham SJ. Inflammatory bowel disease and colon cancer. Recent Results Cancer Res 2011;185:99–115.
  • Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007;133:1099–105; quiz 340-1.
  • Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526–35.
  • Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004;126:451–9.
  • Wang FY, Arisawa T, Tahara T, Takahama K, Watanabe M, Hirata I, et al. Aberrant DNA methylation in ulcerative colitis without neoplasia. Hepatogastroenterology 2008;55:62–5.
  • Fujiwara I, Yashiro M, Kubo N, Maeda K, Hirakawa K. Ulcerative colitis-associated colorectal cancer is frequently associated with the microsatellite instability pathway. Dis Colon Rectum 2008;51:1387–94.
  • Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7–17.
  • Rabinovitch PS, Dziadon S, Brentnall TA, Emond MJ, Crispin DA, Haggitt RC, et al. Pancolonic chromosomal instability precedes dysplasia and cancer in ulcerative colitis. Cancer Res 1999;59:5148–53.
  • Fozard JB, Quirke P, Dixon MF, Giles GR, Bird CC. DNA aneuploidy in ulcerative colitis. Gut 1986;27:1414–18.
  • Holzmann K, Klump B, Borchard F, Hsieh CJ, Kuhn A, Gaco V, et al. Comparative analysis of histology, DNA content, p53 and Ki-ras mutations in colectomy specimens with long-standing ulcerative colitis. Int J Cancer 1998;76:1–6.
  • Leedham SJ, Graham TA, Oukrif D, McDonald SA, Rodriguez-Justo M, Harrison RF, et al. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia. Gastroenterology 2009;136:542–50; e6.
  • Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointest Endosc 2007;65:998–1004.
  • Sjoqvist U. Dysplasia in ulcerative colitis–clinical consequences? Langenbecks Arch Surg 2004;389:354–60.
  • Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther 2007;25:657–68.
  • Eaden J, Abrams K, McKay H, Denley H, Mayberry J. Inter-observer variation between general and specialist gastrointestinal pathologists when grading dysplasia in ulcerative colitis. J Pathol 2001;194:152–7.
  • Odze RD, Tomaszewski JE, Furth EE, Feldman MD, Diallo R, Poremba C, et al. Variability in the diagnosis of dysplasia in ulcerative colitis by dynamic telepathology. Oncol Rep 2006;16:1123–9.
  • Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634–48.
  • Araujo SE, Bernardo WM, Habr-Gama A, Kiss DR, Cecconello I. DNA ploidy status and prognosis in colorectal cancer: a meta-analysis of published data. Dis Colon Rectum 2007;50:1800–10.
  • Sinicrope FA, Rego RL, Halling KC, Foster N, Sargent DJ, La Plant B, et al. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients. Gastroenterology 2006;131:729–37.
  • Habermann J, Lenander C, Roblick UJ, Kruger S, Ludwig D, Alaiya A, et al. Ulcerative colitis and colorectal carcinoma: DNA-profile, laminin-5 gamma2 chain and cyclin A expression as early markers for risk assessment. Scand J Gastroenterol 2001;36:751–8.
  • Rubin CE, Haggitt RC, Burmer GC, Brentnall TA, Stevens AC, Levine DS, et al. DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611–20.
  • Befrits R, Hammarberg C, Rubio C, Jaramillo E, Tribukait B. DNA aneuploidy and histologic dysplasia in long-standing ulcerative colitis. A 10-year follow-up study. Dis Colon Rectum 1994;37:313–19; discussion 9-20.
  • Gerling M, Meyer KF, Fuchs K, Igl BW, Fritzsche B, Ziegler A, et al. High Frequency of Aneuploidy Defines Ulcerative Colitis-Associated Carcinomas: a Comparative Prognostic Study to Sporadic Colorectal Carcinomas. Ann Surg 2010 [Epub ahead of print].
  • Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759–67.
  • Ostwald C, Linnebacher M, Weirich V, Prall F. Chromosomally and microsatellite stable colorectal carcinomas without the CpG island methylator phenotype in a molecular classification. Int J Oncol 2009;35:321–7.
  • Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 1999;96:8681–6.
  • Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, et al. The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 2007;132:127–38.
  • Kouri M. DNA ploidy of colorectal carcinoma by tumour site, gender and history of noncolorectal malignancies. Oncology 1993;50:41–5.
  • Ngoi SS, Staiano-Coico L, Godwin TA, Wong RJ, DeCosse JJ. Abnormal DNA ploidy and proliferative patterns in superficial colonic epithelium adjacent to colorectal cancer. Cancer 1990;66:953–9.
  • Saccani Jotti G, Fontanesi M, Orsi N, Sarli L, Pietra N, Peracchia A, et al. DNA content in human colon cancer and non-neoplastic adjacent mucosa. Int J Biol Markers 1995;10:11–16.
  • Gryfe R. Inherited colorectal cancer syndromes. Clin Colon Rectal Surg 2009;22:198–208.
  • Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931–68.
  • Auer GU, Caspersson TO, Wallgren AS. DNA content and survival in mammary carcinoma. Anal Quant Cytol 1980;2:161–5.
  • Cohen J. Weighed kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968;70:213–20.
  • Gerrits MM, Chen M, Theeuwes M, van Dekken H, Sikkema M, Steyerberg EW, et al. Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study. Cell Oncol (Dordr) 2011;34:107–17.
  • Keller R, Foerster EC, Kohler A, Floer B, Winde G, Terpe HJ, et al. Diagnostic value of DNA image cytometry in ulcerative colitis. Dig Dis Sci 2001;46:870–8.
  • Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, et al. Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 1992;103:1602–10.
  • Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol 2003;36:S70–4; discussion S94-6.
  • Kuester D, Dalicho S, Monkemuller K, Benedix F, Lippert H, Guenther T, et al. Synchronous multifocal colorectal carcinoma in a patient with delayed diagnosis of ulcerative pancolitis. Pathol Res Pract 2008;204:905–10.
  • Meira LB, Bugni JM, Green SL, Lee CW, Pang B, Borenshtein D, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest 2008;118:2516–25.
  • Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000;14:145–53.
  • Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, et al. A critical function for type I interferons in cancer immunoediting. Nat Immunol 2005;6:722–9.
  • Shankaran V, Ikeda H, Bruce AT, White JM, Swanson PE, Old LJ, et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107–11.
  • Alanen KA, Klemi PJ, Joensuu H, Kujari H, Pekkala E. Comparison of fresh, ethanol-preserved, and paraffin- embedded samples in DNA flow cytometry. Cytometry 1989;10:81–5.
  • Chen TL, Luo I, Mikhail N, Raskova J, Raska K Jr. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma. Cytometry 1995;22:181–9.
  • Danque PO, Chen HB, Patil J, Jagirdar J, Orsatti G, Paronetto F. Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparation. Mod Pathol 1993;6:270–5.
  • Suzuki K, Muto T, Masaki T, Morioka Y. Microspectrophotometric DNA analysis in ulcerative colitis with special reference to its application in diagnosis of carcinoma and dysplasia. Gut 1990;31:1266–70.
  • Lanigan D, McLean PA, Curran B, Leader M. Comparison of flow and static image cytometry in the determination of ploidy. J Clin Pathol 1993;46:135–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.